Core Total Assets from 2010 to 2024

CLB Stock  USD 16.53  0.46  2.71%   
Core Laboratories' Total Assets are increasing over the years with stable fluctuation. Total Assets are expected to dwindle to about 550.2 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
1995-09-30
Previous Quarter
592.4 M
Current Value
586.4 M
Quarterly Volatility
165 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Core Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.8 M, Interest Expense of 10.1 M or Selling General Administrative of 34.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.7, Dividend Yield of 0.0022 or PTB Ratio of 6.42. Core financial statements analysis is a perfect complement when working with Core Laboratories Valuation or Volatility modules.
  
This module can also supplement Core Laboratories' financial leverage analysis and stock options assessment as well as various Core Laboratories Technical models . Check out the analysis of Core Laboratories Correlation against competitors.

Latest Core Laboratories' Total Assets Growth Pattern

Below is the plot of the Total Assets of Core Laboratories NV over the last few years. Total assets refers to the total amount of Core Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Core Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Core Laboratories' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Laboratories' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 586.39 M10 Years Trend
Pretty Stable
   Total Assets   
       Timeline  

Core Total Assets Regression Statistics

Arithmetic Mean580,975,905
Geometric Mean529,891,297
Coefficient Of Variation26.44
Mean Deviation75,933,314
Median586,394,999
Standard Deviation153,589,472
Sample Variance23589.7T
Range709.4M
R-Value0.28
Mean Square Error23366T
R-Squared0.08
Significance0.31
Slope9,728,229
Total Sum of Squares330256.2T

Core Total Assets History

2024550.2 M
2023586.4 M
2022578.4 M
2021580.9 M
2020568.6 M
2019774.7 M
2018648.8 M

Other Fundumenentals of Core Laboratories

Core Laboratories Total Assets component correlations

0.410.80.520.70.730.90.82-0.050.440.570.680.480.490.35-0.34-0.470.380.30.370.050.18-0.240.140.16-0.02
0.41-0.170.130.520.28-0.020.370.340.030.1-0.350.370.13-0.050.30.410.66-0.660.45-0.730.40.14-0.260.230.37
0.8-0.170.310.30.480.960.53-0.110.540.510.920.320.350.33-0.43-0.710.090.720.190.440.09-0.390.290.07-0.21
0.520.130.310.770.940.50.86-0.540.170.40.510.090.470.43-0.86-0.38-0.210.4-0.170.44-0.62-0.110.340.13-0.23
0.70.520.30.770.890.520.92-0.220.070.580.340.270.590.3-0.49-0.230.020.060.090.09-0.24-0.060.10.28-0.1
0.730.280.480.940.890.660.97-0.410.20.480.60.280.530.4-0.76-0.42-0.070.360.030.35-0.39-0.090.240.17-0.11
0.9-0.020.960.50.520.660.71-0.230.490.620.910.350.50.4-0.53-0.730.10.650.180.40.0-0.350.30.11-0.24
0.820.370.530.860.920.970.71-0.240.150.50.590.40.490.31-0.65-0.390.020.280.170.27-0.22-0.030.110.16-0.01
-0.050.34-0.11-0.54-0.22-0.41-0.23-0.24-0.05-0.26-0.360.11-0.48-0.380.710.540.44-0.430.29-0.510.610.07-0.36-0.070.39
0.440.030.540.170.070.20.490.15-0.050.370.47-0.210.460.72-0.2-0.370.280.53-0.20.06-0.11-0.820.750.54-0.47
0.570.10.510.40.580.480.620.5-0.260.370.410.040.690.25-0.43-0.59-0.010.33-0.140.18-0.31-0.360.360.31-0.72
0.68-0.350.920.510.340.60.910.59-0.360.470.410.190.440.5-0.66-0.8-0.190.880.00.68-0.19-0.370.420.12-0.25
0.480.370.320.090.270.280.350.40.11-0.210.040.19-0.17-0.4-0.07-0.160.3-0.150.89-0.010.510.62-0.680.010.55
0.490.130.350.470.590.530.50.49-0.480.460.690.44-0.170.73-0.41-0.63-0.140.37-0.330.18-0.4-0.450.640.54-0.54
0.35-0.050.330.430.30.40.40.31-0.380.720.250.5-0.40.73-0.36-0.46-0.080.55-0.410.22-0.39-0.70.840.55-0.44
-0.340.3-0.43-0.86-0.49-0.76-0.53-0.650.71-0.2-0.43-0.66-0.07-0.41-0.360.630.46-0.690.24-0.760.730.13-0.39-0.150.41
-0.470.41-0.71-0.38-0.23-0.42-0.73-0.390.54-0.37-0.59-0.8-0.16-0.63-0.460.630.31-0.760.07-0.640.330.19-0.41-0.270.49
0.380.660.09-0.210.02-0.070.10.020.440.28-0.01-0.190.3-0.14-0.080.460.31-0.430.48-0.760.67-0.1-0.16-0.010.27
0.3-0.660.720.40.060.360.650.28-0.430.530.330.88-0.150.370.55-0.69-0.76-0.43-0.330.83-0.47-0.510.620.19-0.5
0.370.450.19-0.170.090.030.180.170.29-0.2-0.140.00.89-0.33-0.410.240.070.48-0.33-0.280.750.53-0.720.010.63
0.05-0.730.440.440.090.350.40.27-0.510.060.180.68-0.010.180.22-0.76-0.64-0.760.83-0.28-0.59-0.060.260.03-0.32
0.180.40.09-0.62-0.24-0.390.0-0.220.61-0.11-0.31-0.190.51-0.4-0.390.730.330.67-0.470.75-0.590.25-0.58-0.140.65
-0.240.14-0.39-0.11-0.06-0.09-0.35-0.030.07-0.82-0.36-0.370.62-0.45-0.70.130.19-0.1-0.510.53-0.060.25-0.87-0.330.63
0.14-0.260.290.340.10.240.30.11-0.360.750.360.42-0.680.640.84-0.39-0.41-0.160.62-0.720.26-0.58-0.870.38-0.72
0.160.230.070.130.280.170.110.16-0.070.540.310.120.010.540.55-0.15-0.27-0.010.190.010.03-0.14-0.330.38-0.29
-0.020.37-0.21-0.23-0.1-0.11-0.24-0.010.39-0.47-0.72-0.250.55-0.54-0.440.410.490.27-0.50.63-0.320.650.63-0.72-0.29
Click cells to compare fundamentals

About Core Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Core Laboratories income statement, its balance sheet, and the statement of cash flows. Core Laboratories investors use historical funamental indicators, such as Core Laboratories's Total Assets, to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may use each financial statement separately, they are all related. The changes in Core Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Core Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Core Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Core Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets586.4 M550.2 M
Intangibles To Total Assets 0.18  0.26 

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Stock

  0.9NR Newpark Resources Financial Report 7th of May 2024 PairCorr
  0.74TS Tenaris SA ADR Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out the analysis of Core Laboratories Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Dividend Share
0.04
Earnings Share
0.51
Revenue Per Share
10.92
Quarterly Revenue Growth
0.005
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.